Watrium continues its support of Oslo-listed Ultimovacs ASA through participation in a NOK 160 million private placement in the pharmaceutical company. Ultimovacs is developing novel immunotherapies against cancer. The net...
Watrium continues its support of Oslo-listed Ultimovacs ASA through participation in a NOK 160 million private placement in the pharmaceutical company. Ultimovacs is developing novel immunotherapies against cancer. The net...
CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius®, has raised £195 million ($240 million) to fully fund the global commercialisation of the business.
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen...
Watrium supports the listing of DF Capital on AIM as cornerstone investor.
Watrium partners with HitecVision by acquiring the interests of the Gjedebo family in HitecVision AS.
Watrium’s portfolio company Flexiteek International, the global leader in synthetic teak decking and the 2G technology, has reached an agreement to acquire Wilks, manufacturer, and supplier of Dek-King synthetic teak...
Watrium strengthens its investment team with two highly experienced investment professionals.
The combined entity of American Traffic Solutions, Highway Toll Administration and Watrium-owned Euro Parking Collection has rebranded to Verra Mobility and announced that the company will perform a reverse listing...
Watrium has participated in the Series B financing of CMR Surgical, a private company developing a next-generation surgical robot for universal minimal access surgery.
Watrium has merged Euro Parking Collection Plc (EPC) into American Traffic Solutions (ATS) in a deal that will facilitate further growth and global expansion.